AI
Friday, November 24, 2023 11:08:49 PM
I think they knew well about the trial data. They just don't like the fact that what they are doing is no way comparable with what DCVax-L can achieve.
Here is the clinical trial they were all involved and they just got a Nature paper published last month. Can we see the long tail in the survival curve? All patients passed away within 40 months. Did they observe high occurrence rate of pseudo progression? The current combo trial results once published will immediately make obsolete what they were doing.
https://classic.clinicaltrials.gov/ct2/show/NCT03152318?cond=NCT03152318&draw=2&rank=1
https://www.nature.com/articles/s41586-023-06623-2
Here is the clinical trial they were all involved and they just got a Nature paper published last month. Can we see the long tail in the survival curve? All patients passed away within 40 months. Did they observe high occurrence rate of pseudo progression? The current combo trial results once published will immediately make obsolete what they were doing.
https://classic.clinicaltrials.gov/ct2/show/NCT03152318?cond=NCT03152318&draw=2&rank=1
https://www.nature.com/articles/s41586-023-06623-2
